Algonquin Power is undervalued, Industrial Alliance says

With its joint venture and 25 per cent stake in Atlantic Yield now completed, Algonquin Power & Utilities Corp. (Algonquin Power & Utilities Corp. Stock Quote, Chart, News: TSX:AQN, NYSE:AQN) is that much more attractive, says analyst Jeremy Rosenfield of Industrial Alliance Securities, who rates the stock a “Strong Buy” with a $17.00 price target.

Renewable energy and utility distribution company Algonquin Power announced on Friday the completion of its AAGES joint venture with Seville, Spain-based Abengoa SA, which will focus on global clean energy and water infrastructure assets. The deal involves Algonquin’s purchase from Abengoa of a 25 per cent equity interest in Atlantica Yield, a clean energy owner/operator with 22 facilities worldwide.

The move puts APUC as a key player in global clean energy and water infrastructure, says Algonquin’s CEO, Ian Robertson.

“We are pleased to be partners with Abengoa in AAGES, which provides APUC with a strong and risk-balanced entry into new international markets with a long-standing and experienced partner,” Robertson says in a press release. “As well, through Atlantica, APUC benefits from having an experienced international operator for new projects developed by AAGES as well as an interest in an attractively-priced portfolio of high quality, international operating assets that is accretive to APUC’s earnings and cash flow per share.”

Rosenfield sees APUC’s strategic initiatives paying off immediately by adding to its EPS, with the analyst forecasting initial earnings accretion of ~$0.02 to $0.05 per share. Moreover, the moves will support the company’s long-term growth in international markets, he says.

“We see long-term potential upside from project development at AAGES and future asset dropdown transactions to AY,” says Rosenfield in a research update to clients on Friday. “The Company has identified ~US$600-800 million of initial investment opportunities with the next two to three years, and ~US$200 million/year thereafter.”

“In our view, AQN remains the most well-balanced investment option in the sector, supported by the Company’s (1) diversified business model (power & utilities), (2) leverage to multiple investment themes (i.e., investments regulated utilities and non- regulated power), (3) healthy near-term organic and M&A-based growth (forecasted 8-10 per cent EPS and FFO/sh growth, and 15 per cent + FCF/sh growth through 2021), and (4) attractive dividend growth (~10 per cnet/year through 2021),” the analyst writes.

The analyst thinks AQN will generate EBITDA of $897 million in 2018 and $961 in 2019. Rosenfield’s “Strong Buy” rating and $17.00 price target (representing a 36.0 per cent potential return including dividends) are unchanged.

We Hate Paywalls Too!

At Cantech Letter we prize independent journalism like you do. And we don't care for paywalls and popups and all that noise That's why we need your support. If you value getting your daily information from the experts, won't you help us? No donation is too small.

Make a one-time or recurring donation

Tagged with: aqn
Jayson MacLean

Jayson is a writer, researcher and educator with a PhD in political philosophy from the University of Ottawa. His interests range from bioethics and innovations in the health sciences to governance, social justice and the history of ideas.

Recent Posts

Is Peloton Stock a Buy? (May, 2024)

Following news of a restructuring, Roth MKM analyst George Kelly has chopped his price target on Peloton (Peloton Stock Quote,… [Read More]

2 hours ago

Is Ascend Wellness stock a buy?

Ahead of the company's first quarter results, Beacon analyst Russell Stanley thinks Ascend Wellness (Ascend Wellness Stock Quote, Chart, News,… [Read More]

3 hours ago

Paradigm chops price target on Snipp Interactive

Following the company's fourth quarter results, Paradigm Capital analyst Daniel Rosenberg has cut his price target on Snipp Interactive (Snipp… [Read More]

3 hours ago

It’s time to buy cannabis stocks, this analyst says

A major development came down the pipe this week at the U.S. Drug Enforcement Agency has reportedly decided to reschedule… [Read More]

18 hours ago

Is Generac stock a buy?

Following the company's first quarter results, Roth MKM analyst Chip Moore remains neutral on Generac Holdings (Generac Holdings Stock Quote,… [Read More]

1 day ago

Bombardier is a buy, Desjardins says (May, 2024)

The stock has climbed slowly but surely since last October. But is there still money to be made on Bombardier?… [Read More]

1 day ago